L26/P-628 Pulling vs flicking trophectoderm biopsy in preimplantation genetic testing for aneuploidies: association with preterm birth and placental abruption
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.958 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von L. Duarte Weissheimer und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does the choice of trophectoderm biopsy technique during preimplantation genetic testing for aneuploidies (PGT-A) influence obstetric and perinatal outcomes? Summary answer The flicking biopsy technique was associated with a lower risk of preterm birth and placental abruption compared with the pulling technique. What is known already PGT-A has refined the selection of euploid embryos in ART, contributing to reduced rates of miscarriage and multiple pregnancy. However, PGT-A relies on invasive trophectoderm biopsy, which may affect placental development and has been inconsistently associated with adverse obstetric and perinatal outcomes. Importantly, trophectoderm biopsy is highly technique-dependent, with substantial inter-laboratory variation in embryo manipulation and cell collection. This variability may partly explain inconsistent findings and supports the hypothesis that certain biopsy approaches may be safer than others. Therefore, evaluating obstetric and perinatal outcomes according to biopsy technique is essential to inform procedural safety while non-invasive alternatives continue to evolve. Study design, size, duration This retrospective single-center cohort study included 383 live births after PGT-A between 2016 and 2023. Only top-quality (AA, AB, BA, BB) euploid blastocyst transfers were included. Obstetrical and perinatal outcomes were compared between pulling and flicking trophectoderm biopsy techniques. Core perinatal data (mode of delivery, gestational age and birthweight) were available for all 383 live births, while extended obstetric and perinatal outcomes were obtained through structured parental questionnaires, with responses available for 178 live births. Participants/materials, setting, methods In the pulling approach, assisted hatching was performed on day-3 embryos and 5–7 trophectoderm cells were detached at the blastocyst stage using 2-10 laser pulses. In the flicking approach, biopsy was performed exclusively on fully expanded blastocysts, with three laser pulses used to detach 5-7 trophectoderm cells without prior day-3 manipulation. Outcomes were compared by technique using modified Poisson regression with robust variance estimate adjusted for maternal age, BMI, endometrial preparation, and multiple pregnancies. Main results and the role of chance Among 383 live births (369 pregnancies), 98 (91) resulted from trophectoderm biopsy performed using the pulling technique and 285 (278) using the flicking technique. Extended obstetric and perinatal outcome data were available for 42 (42) pulling-derived and 136 (133) flicking-derived live births. Baseline characteristics were largely comparable between groups; variables showing imbalance, including multiple pregnancy rate, endometrial preparation protocol, and maternal BMI, were accounted for in adjusted analyses, with maternal age included a priori given its established relevance to obstetric outcomes. Among pregnancies resulting in live birth, preterm birth (<37 weeks) occurred in 27/91 (29.7%) of pulling-derived pregnancies and 42/278 (15.1%) of flicking-derived pregnancies. In adjusted analyses, flicking biopsy was associated with a significantly lower risk of preterm birth compared with pulling biopsy (adjusted RR 0.62, 95% CI 0.40–0.97). Placental abruption occurred in 3/42 (7.1%) pulling-derived and 2/133 (1.5%) flicking-derived pregnancies with extended outcome data; flicking biopsy was associated with a significantly lower adjusted risk (RR 0.11, 95% CI 0.01–0.85), although events were rare. No significant differences were observed between biopsy techniques in mode of delivery, low birthweight (<2500 g), macrosomia (>4000 g), hypertensive disorders of pregnancy, placenta previa, premature rupture of membranes, gestational diabetes mellitus, or congenital anomalies. Limitations, reasons for caution This retrospective, single-center cohort study is subject to residual confounding. Extended obstetric and perinatal outcomes were collected via parental questionnaires, with incomplete response rates introducing potential bias. Findings require confirmation in prospective multicenter studies. Wider implications of the findings Taken together, these findings suggest that trophectoderm biopsy technique may influence obstetric and perinatal outcomes, particularly preterm birth and placental abruption, potentially through effects on early placentation. Confirmation in prospective studies could identify biopsy technique as a modifiable factor to optimize the safety and health of PGT-A-derived pregnancies and offspring. Trial registration number No
Zitieren
APA
Weissheimer, L. D., Frantz, N., & Kulmann, M. R. (2026). L26/P-628 Pulling vs flicking trophectoderm biopsy in preimplantation genetic testing for aneuploidies: association with preterm birth and placental abruption. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.958
Vancouver
Weissheimer LD, Frantz N, Kulmann MR. L26/P-628 Pulling vs flicking trophectoderm biopsy in preimplantation genetic testing for aneuploidies: association with preterm birth and placental abruption. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.958
BibTeX
@article{Weissheimer2026,
author = {Weissheimer, L. Duarte and Frantz, N. and Kulmann, M.I. Roos},
title = {L26/P-628 Pulling vs flicking trophectoderm biopsy in preimplantation genetic testing for aneuploidies: association with preterm birth and placental abruption},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.958}
}
EUVIMED